Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden
· Delayed Price · Currency is SEK 32.45
+0.20 (0.62%)
At close: Dec 5, 2025
Xspray Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 197.98 | 208.24 | 166.3 | 120.17 | 271.88 | 325.6 | Upgrade
|
| Cash & Short-Term Investments | 197.98 | 208.24 | 166.3 | 120.17 | 271.88 | 325.6 | Upgrade
|
| Cash Growth | 164.83% | 25.21% | 38.39% | -55.80% | -16.50% | 55.14% | Upgrade
|
| Other Receivables | 4.65 | 4.02 | 4.17 | 2.59 | 2.5 | 3.32 | Upgrade
|
| Receivables | 4.65 | 4.02 | 4.17 | 2.59 | 2.5 | 3.32 | Upgrade
|
| Inventory | 27.46 | 20.34 | 43.78 | 8.55 | 6.2 | - | Upgrade
|
| Prepaid Expenses | 4.12 | 2.48 | 3.57 | 0.93 | 1.48 | 2.1 | Upgrade
|
| Other Current Assets | - | 0 | - | -0 | -0 | - | Upgrade
|
| Total Current Assets | 234.21 | 235.07 | 217.82 | 132.23 | 282.07 | 331.02 | Upgrade
|
| Property, Plant & Equipment | 73.03 | 79.18 | 107.65 | 64.6 | 44.6 | 42.67 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Long-Term Deferred Charges | 509.71 | 478.93 | 436.78 | 385.6 | 296.24 | 231.62 | Upgrade
|
| Other Long-Term Assets | 3.25 | 3.17 | 3.02 | 3 | - | - | Upgrade
|
| Total Assets | 820.2 | 796.34 | 765.26 | 585.43 | 622.9 | 605.3 | Upgrade
|
| Accounts Payable | 13.42 | 17.08 | 12.47 | 14.79 | 16.87 | 8.44 | Upgrade
|
| Accrued Expenses | 12.68 | 18.63 | 16.31 | 11.41 | 10.3 | 8.54 | Upgrade
|
| Short-Term Debt | - | 96 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 5.31 | 5.11 | 4.86 | 1.57 | 2.05 | 1.99 | Upgrade
|
| Other Current Liabilities | 3.46 | 9.31 | 6.26 | 1.09 | 0.75 | 0.86 | Upgrade
|
| Total Current Liabilities | 34.86 | 146.14 | 39.9 | 28.85 | 29.97 | 19.82 | Upgrade
|
| Long-Term Leases | 23.08 | 27.11 | 31.95 | 0.56 | 1.19 | 2.9 | Upgrade
|
| Other Long-Term Liabilities | 120.53 | -0 | - | - | - | - | Upgrade
|
| Total Liabilities | 178.47 | 173.25 | 71.85 | 29.41 | 31.15 | 22.72 | Upgrade
|
| Common Stock | 41.74 | 37.14 | 31.25 | 22.68 | 20.68 | 18.89 | Upgrade
|
| Additional Paid-In Capital | 1,574 | 1,425 | 1,216 | 907.42 | 813.48 | 709.41 | Upgrade
|
| Retained Earnings | -974.06 | -840.25 | -554.72 | -374.08 | -242.41 | -145.71 | Upgrade
|
| Comprehensive Income & Other | - | 1 | 0.79 | - | - | - | Upgrade
|
| Shareholders' Equity | 641.73 | 623.1 | 693.41 | 556.02 | 591.75 | 582.59 | Upgrade
|
| Total Liabilities & Equity | 820.2 | 796.34 | 765.26 | 585.43 | 622.9 | 605.3 | Upgrade
|
| Total Debt | 28.39 | 128.22 | 36.81 | 2.13 | 3.23 | 4.88 | Upgrade
|
| Net Cash (Debt) | 169.6 | 80.02 | 129.5 | 118.04 | 268.65 | 320.72 | Upgrade
|
| Net Cash Growth | 312.11% | -38.21% | 9.70% | -56.06% | -16.23% | 56.80% | Upgrade
|
| Net Cash Per Share | 4.62 | 2.41 | 4.87 | 5.60 | 13.96 | 18.63 | Upgrade
|
| Filing Date Shares Outstanding | 41.74 | 37.14 | 31.25 | 22.68 | 20.68 | 18.89 | Upgrade
|
| Total Common Shares Outstanding | 41.74 | 37.14 | 31.25 | 22.68 | 20.68 | 18.89 | Upgrade
|
| Working Capital | 199.35 | 88.93 | 177.91 | 103.38 | 252.1 | 311.2 | Upgrade
|
| Book Value Per Share | 15.37 | 16.78 | 22.19 | 24.52 | 28.61 | 30.84 | Upgrade
|
| Tangible Book Value | 641.73 | 623.1 | 693.41 | 556.02 | 591.75 | 582.59 | Upgrade
|
| Tangible Book Value Per Share | 15.37 | 16.78 | 22.19 | 24.52 | 28.61 | 30.84 | Upgrade
|
| Machinery | - | 51.5 | 52.12 | 49.82 | 46.96 | 39.87 | Upgrade
|
| Construction In Progress | - | 41.39 | 59.37 | 46.57 | 20.04 | 15.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.